Clinical Trial Update: TAS-102 Plus Radiotherapy in Elderly ESCC [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial evaluating TAS-102 in combination with radiotherapy for elderly patients with esophageal squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• TAS-102 (Lonsurf) (trifluridine/tipiracil)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: ESCC, TAS 102 | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING